About Cellular Origins
Cellular Origins is a company based in Cambridge (United Kingdom) founded in 2021. It operates as a B2B. Cellular Origins has raised $40 million across 1 funding round from investors including Johnson & Johnson, Highland Europe and BGF. Cellular Origins offers products and services including Constellation. Cellular Origins operates in a competitive market with competitors including Multiply Labs, Shenzhen Shenyan Biotechnology, ThermoGenesis, Cytera and Guangdong Bogong Medical Technology, among others.
- Headquarter Cambridge, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cellular Origins Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$40 M (USD)
in 1 rounds
-
Latest Funding Round
$40 M (USD), Series A
Dec 09, 2025
-
Investors
Johnson & Johnson
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cellular Origins
Cellular Origins offers a comprehensive portfolio of products and services, including Constellation.
Robotic ecosystem for scaling cell therapy manufacturing processes.
People of Cellular Origins
Unlock access to complete
Unlock access to complete
Funding Insights of Cellular Origins
Cellular Origins has successfully raised a total of $40M through 1 strategic funding round. The most recent funding activity was a Series A round of $40 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cellular Origins
Cellular Origins has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Johnson & Johnson, Highland Europe and BGF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage consumer and enterprise technology companies are funded.
|
Locked | Locked | Locked | |
|
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Cellular Origins
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cellular Origins
Investment portfolio details for Cellular Origins
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cellular Origins
Detailed financials for Cellular Origins
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cellular Origins Comparisons
Peer comparison for Cellular Origins
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cellular Origins
Cellular Origins operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Multiply Labs, Shenzhen Shenyan Biotechnology, ThermoGenesis, Cytera and Guangdong Bogong Medical Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision medicines are manufactured via robotic systems for cell therapies.
|
|
| Locked | Locked | Locked |
Automated cell processing systems are developed for gene therapies.
|
|
| Locked | Locked | Locked |
Automated technologies for cell-based therapeutics and bio-processing are developed.
|
|
| Locked | Locked | Locked |
Automated cell culture devices using T-flasks and incubators are developed.
|
|
| Locked | Locked | Locked |
Robotic solutions for life science research are developed.
|
Detailed competitors of Cellular Origins
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cellular Origins
Complete news archive for Cellular Origins
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cellular Origins
Cellular Origins was founded in 2021 and raised its 1st funding round 4 years after it was founded.
Cellular Origins is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Cellular Origins is a funded company, having raised a total of $40M across 1 funding round to date.
Cellular Origins focuses on automating and digitalizing cell therapy manufacturing to enable scalable production of life-saving treatments. Based in Melbourn, United Kingdom, the company partners with technology providers to integrate existing processes into a robotic ecosystem, reducing labor and optimizing space without altering core methods. This approach ensures efficiency, compliance, and faster delivery of therapies to patients worldwide.
Cellular Origins's top competitors include Multiply Labs, Celltrio and ThermoGenesis.
Cellular Origins offers Constellation.
Cellular Origins has 5 investors. Key investors include Johnson & Johnson, Highland Europe, BGF, NYBC Ventures, and TTP Group.